DNAprint Genomics (DNAG)

[worktoplay]

frog...I would be happy to chime in as soon as you offer a response to this post:

http://investorshub.com/boards/read_msg.asp?message_id=4315110

I believe where we left off was your statement that, "They only ever talk about a Major equity position and gaining 'access' to the drug pipeline, never operational control...and, "Given that the 'Control' word has never been mentioned, it is a safe bet that DNAP will NOT have voting control over Biofrontera.

I defy anyone to produce evidence to the contrary."

As the evidence would seem to indicate, I think DNAPrint having ownership of 51.7% of the equity, and 68% voting power in determining the company business plan constitutes effective control of the business operations moving forward.

Wouldn't you agree?

Later,
W2P